Deep knowledge on
small-molecule drugs and
the 100,000 global patents
covering them

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: AEROSPAN HFA

« Back to Dashboard
Aerospan Hfa is a drug marketed by Meda Pharms Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has twelve patent family members in eleven countries.

The generic ingredient in AEROSPAN HFA is flunisolide. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the flunisolide profile page.

Summary for Tradename: AEROSPAN HFA

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list2

Pharmacology for Tradename: AEROSPAN HFA

Clinical Trials for: AEROSPAN HFA

Flunisolide HFA in Children With Small Airway Disease
Status: Recruiting Condition: Asthma

Mentored Patient-Oriented Research Career Development Award
Status: Recruiting Condition: Asthma; Distal Lung Inflammation

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meda Pharms Inc
AEROSPAN HFA
flunisolide
AEROSOL, METERED;INHALATION021247-001Jan 27, 2006RXYes5,776,433<disabled>Y <disabled>
Meda Pharms Inc
AEROSPAN HFA
flunisolide
AEROSOL, METERED;INHALATION021247-001Jan 27, 2006RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AEROSPAN HFA

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Meda Pharms Inc
AEROSPAN HFA
flunisolide
AEROSOL, METERED;INHALATION021247-001Jan 27, 20065,776,433<disabled>
Meda Pharms Inc
AEROSPAN HFA
flunisolide
AEROSOL, METERED;INHALATION021247-001Jan 27, 20065,980,867<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: AEROSPAN HFA

Country Document Number Publication Date
Germany69424181May 31, 2000
Australia1098695Jul 10, 1995
European Patent Office0735884Apr 26, 2000
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc